-15.4%
JBLU vs GSK
+21.8%
-37.2%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.2% | 0.0% | +0.2% | +0.2% |
| 7D | -5.0% | -3.5% | -1.4% | -3.5% |
| 30D | -23.9% | -3.4% | -20.4% | -22.8% |
| 3M | -11.6% | -8.1% | -3.5% | -8.6% |
| 6M | -0.2% | -11.1% | +10.9% | +5.2% |
| YTD | -3.3% | +0.7% | -4.0% | +3.7% |
| 1Y | -15.4% | +20.1% | -35.5% | -5.9% |
| All | -15.4% | +21.8% | -37.2% | -5.9% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling